BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32630147)

  • 1. Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth.
    Ashour N; Angulo JC; González-Corpas A; Orea MJ; Lobo MVT; Colomer R; Colás B; Esteller M; Ropero S
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630147
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen MS; Lo YH; Chen X; Williams CS; Donnelly JM; Criss ZK; Patel S; Butkus JM; Dubrulle J; Finegold MJ; Shroyer NF
    Mol Cancer Res; 2019 Mar; 17(3):697-708. PubMed ID: 30606770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells.
    Dwivedi PP; Anderson PH; Omdahl JL; Grimes HL; Morris HA; May BK
    Endocr Relat Cancer; 2005 Jun; 12(2):351-65. PubMed ID: 15947108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
    Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
    Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
    Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
    Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5.
    Duan Z; Person RE; Lee HH; Huang S; Donadieu J; Badolato R; Grimes HL; Papayannopoulou T; Horwitz MS
    Mol Cell Biol; 2007 Oct; 27(19):6889-902. PubMed ID: 17636019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
    Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K; Inoue S
    Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
    Kazanjian A; Wallis D; Au N; Nigam R; Venken KJ; Cagle PT; Dickey BF; Bellen HJ; Gilks CB; Grimes HL
    Cancer Res; 2004 Oct; 64(19):6874-82. PubMed ID: 15466176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1.
    Vadnais C; Chen R; Fraszczak J; Yu Z; Boulais J; Pinder J; Frank D; Khandanpour C; Hébert J; Dellaire G; Côté JF; Richard S; Orthwein A; Drobetsky E; Möröy T
    Nat Commun; 2018 Apr; 9(1):1418. PubMed ID: 29651020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells.
    Dwivedi PP; Anderson PH; Tilley WD; May BK; Morris HA
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):742-6. PubMed ID: 17207994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.
    Botezatu L; Michel LC; Helness A; Vadnais C; Makishima H; Hönes JM; Robert F; Vassen L; Thivakaran A; Al-Matary Y; Lams RF; Schütte J; Giebel B; Görgens A; Heuser M; Medyouf H; Maciejewski J; Dührsen U; Möröy T; Khandanpour C
    Exp Hematol; 2016 Aug; 44(8):713-726.e14. PubMed ID: 27216773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
    Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
    Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development.
    Yücel R; Kosan C; Heyd F; Möröy T
    J Biol Chem; 2004 Sep; 279(39):40906-17. PubMed ID: 15252036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.